Short answer
MIMEDX GROUP, INC. (MDXG) filed an 8-K current report with the SEC on February 25, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure). Q1 2025 earnings press release filed via Exhibit: refer to attached exhibit for revenue, earnings, and guidance figures.
MIMEDX GROUP, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2025 earnings press release filed via Exhibit: refer to attached exhibit for revenue, earnings, and guidance figures
- Furnished under Item 2.02, meaning not "filed" for liability purposes under Exchange Act Section 18
- Standard Reg FD-compliant disclosure; no forward-looking obligation assumed by company
Item 7.01 · Regulation FD Disclosure
- Q4 and full-year 2025 earnings call scheduled Feb 25, 2026 at 4:30 PM ET
- Slide deck (Exhibit 99.2) and updated investor presentation (Exhibit 99.3) accompany the call
- Key financials for FY2025 will be disclosed: monitor exhibits for revenue, margin, and guidance figures
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other MIMEDX GROUP, INC. 8-K filings
Get the next MDXG 8-K as it lands
Follow MDXG for push alerts, or ask the research agent what this filing means.